151 related articles for article (PubMed ID: 20501772)
21. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
[TBL] [Abstract][Full Text] [Related]
22. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis.
Kokkonen H; Söderström I; Rocklöv J; Hallmans G; Lejon K; Rantapää Dahlqvist S
Arthritis Rheum; 2010 Feb; 62(2):383-91. PubMed ID: 20112361
[TBL] [Abstract][Full Text] [Related]
24. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphoma and type of tobacco smoke.
Stagnaro E; Tumino R; Parodi S; Crosignani P; Fontana A; Masala G; Miligi L; Nanni O; Ramazzotti V; Rodella S; Senoiri Constantini A; Vigano C; Vindigni C; Vineis P
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):431-7. PubMed ID: 15006920
[TBL] [Abstract][Full Text] [Related]
26. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort.
Maskarinec G; Erber E; Gill J; Cozen W; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):196-203. PubMed ID: 18187389
[TBL] [Abstract][Full Text] [Related]
27. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326
[TBL] [Abstract][Full Text] [Related]
28. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
30. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
31. Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes.
Cocco P; Brennan P; Ibba A; de Sanjosé Llongueras S; Maynadié M; Nieters A; Becker N; Ennas MG; Tocco MG; Boffetta P
Occup Environ Med; 2008 Feb; 65(2):132-40. PubMed ID: 17699548
[TBL] [Abstract][Full Text] [Related]
32. Alcohol drinking and risk of non-Hodgkin's lymphoma.
Tavani A; Gallus S; La Vecchia C; Franceschi S
Eur J Clin Nutr; 2001 Oct; 55(10):824-6. PubMed ID: 11593342
[TBL] [Abstract][Full Text] [Related]
33. Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.
Bortolin MT; Tedeschi R; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
Cytokine; 2012 Oct; 60(1):90-5. PubMed ID: 22795293
[TBL] [Abstract][Full Text] [Related]
34. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
35. Prediagnostic circulating polyomavirus antibody levels and risk of non-Hodgkin lymphoma.
Teras LR; Rollison DE; Pawlita M; Michel A; Blase JL; Willhauck-Fleckenstein M; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):477-80. PubMed ID: 25488906
[TBL] [Abstract][Full Text] [Related]
36. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
[TBL] [Abstract][Full Text] [Related]
37. Plasma cytokine profiles at diagnosis in pediatric patients with non-hodgkin lymphoma.
Mellgren K; Hedegaard CJ; Schmiegelow K; Müller K
J Pediatr Hematol Oncol; 2012 May; 34(4):271-5. PubMed ID: 22430582
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
Uskudar Teke H; Gulbas Z; Bal C
J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
40. Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan.
Tseng CH
Metabolism; 2012 Jul; 61(7):1003-9. PubMed ID: 22237115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
